- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech High And Sustainable
Taiwanese Pharmaceuticals & Biotech High And Sustainable
Results
2
0 new
Companies in a sound financial shape with a dividend yield of more than 5%.
2 companies
PharmaEngine
Market Cap: NT$10.3b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$71.70
7D
-1.1%
1Y
-24.0%
TTY Biopharm
Market Cap: NT$20.4b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$82.20
7D
3.7%
1Y
9.3%